What is Artiva Biotherapeutics, Inc.'s price / book?

Artiva Biotherapeutics, Inc. (ARTV) reported price / book of 1.8× in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s price / book changed year-over-year?

Artiva Biotherapeutics, Inc.'s price / book increased by 318.5% year-over-year, from 0.4× to 1.8×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Artiva Biotherapeutics, Inc. ARTV Price / book

Price / book at other companies

Bristol-Myers SquibbBMY

6.2×-1.0×

Gilead SciencesGILD

7.4×+0.1×

Kyverna Therapeutics, Inc.KYTX

2.7×+2.3×

Allogene TherapeuticsALLO

2.1×+1.3×

Immix Biopharma, Inc.IMMX

5.7×+0.9×

Cullinan Therapeutics, Inc.CGEM

1.5×+0.3×

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

market cap/total stockholders equity=1.8×

Based on the most recent quarter.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s price / book?: Artiva Biotherapeutics, Inc. (ARTV) reported price / book of 1.8× in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s price / book changed year-over-year?: Artiva Biotherapeutics, Inc.'s price / book increased by 318.5% year-over-year, from 0.4× to 1.8×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.